Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - ITC Order 31 Construing the Terms of the Asserted Claims of the Patent at Issue

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

l2007s

Rank: President [?]

Points: 18410 [?]

Votes: 123 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

ITC Order 31 Construing the Terms of the Asserted Claims of the Patent at Issue

posted on Apr 19, 2013 12:21PM

this one is confidential

1 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply